GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001818331-22-000069
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $36.17M | $47.02M | $30.10M |
| Net Income | -$85.74M | -$46.16M | -$32.05M |
| EPS Diluted | -$8.38 | -$41.94 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end
